CASI Pharmaceuticals Inc CASI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
2.44quote price arrow down-0.07 (-2.79%)
Volume
8,927
52 week range
1.85 - 8.48
Loading...
  • Open2.51
  • Day High2.58
  • Day Low2.44
  • Prev Close2.51
  • 52 Week High8.48
  • 52 Week High Date12/12/23
  • 52 Week Low1.85
  • 52 Week Low Date06/16/23

Key Stats

  • Market Cap32.699M
  • Shares Out13.40M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-65.92

KEY STATS

  • Open2.51
  • Day High2.58
  • Day Low2.44
  • Prev Close2.51
  • 52 Week High8.48
  • 52 Week High Date12/12/23
  • 52 Week Low1.85
  • 52 Week Low Date06/16/23
  • Market Cap32.699M
  • Shares Out13.40M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-65.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.02
  • P/E (TTM)-1.21
  • Fwd P/E (NTM)-8.41
  • EBITDA (TTM)-25.28M
  • ROE (TTM)-78.44%
  • Revenue (TTM)33.879M
  • Gross Margin (TTM)59.19%
  • Net Margin (TTM)-77.37%
  • Debt To Equity (MRQ)78.19%

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CASI Pharmaceuticals Inc

 

Profile

MORE
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan...
Wei-Wu He Ph.D.
Chairman of the Board, Chief Executive Officer
Wei Zhang Ph.D.
President, Principal Financial Officer
Chunhua Wang
Chief Operating Officer
Huang Hai
Global Chief Commercial Officer, Executive Vice President, General Manager of Casi China
Alexander Zukiwski M.D.
Executive Vice President, Chief Medical Officer
Wei Gao
General Counsel
Kun Qian
Vice President, Controller
Address
9620 Medical Center Drive, Suite 300
Beijing, BEJ
100025
China

Top Peers

SYMBOLLASTCHG%CHG
CPIX
Cumberland Pharmaceuticals Inc
1.61-0.03-1.83%
BFRI
Biofrontera Inc
1.66+0.16+11.04%
RVLPQ
RVL Pharmaceuticals PLC
0.00UNCHUNCH
ELUT
Elutia Inc
2.83-0.04-1.43%
NOVNQ
NVN Liquidation Inc
0.0008UNCHUNCH